Elorac, Inc. Announces Launch of Novel, Steroid-Free, Prescription Cream for Psoriasis

Now patients with mild to moderate plaque psoriasis have a new topical treatment option available by prescription. Zithranol-RR (anthralin rapid release microcrystalline encapsulated cream, 1.2%), is an innovative topical therapy for plaque psoriasis according to Elorac, Inc., a privately held emerging dermatology company. Zithranol-RR provides an advanced delivery system for anthralin achieving long remission times with no long-term side effects in a steroid-free, silky cream.

While there is no cure for psoriasis, treatment can clear psoriatic skin for periods of time. Zithranol-RR contains the active ingredient anthralin which has been shown to clear psoriasis and keep it in remission for long periods of time with only once-a-day application.